We investigated the expression of sulfoglycolipids in several gynecolo
gical cancer cell lines by metabolic labeling with S-35-sulfate as wel
l as the activity of GalCer sulfotransferase (ST) and arylsulfatase A
(ASA), enzymes which are responsible for the synthesis and degradation
of sulfoglycolipids. The endometrial carcinoma cell lines expressed s
ulfoglycolipids and showed ST activity, indicating that increased synt
hesis of sulfoglycolipids due to elevated ST activity is a characteris
tic of endometrial carcinoma that distinguishes it from other carcinom
as. These cell lines could provide a useful model for studying the fun
ctions of sulfoglycolipids as well as biological properties of ST in c
ancer cells.